Ellen C. Zwarthoff
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
A Molecular Urine Assay to Detect Recurrences During Surveillance of High-Risk Non-Muscle Invasive Bladder Cancer.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: March 11, 2024
A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy.
Journal: European urology open science
Published: February 20, 2024
PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG.
Journal: World journal of urology
Published: January 29, 2024
Comprehensive genomic characterization of early-stage bladder cancer.
Journal: Nature genetics
Published: October 31, 2023
A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines.
Journal: European urology oncology
Published: April 24, 2022
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients.
Journal: Urologic oncology
Published: August 29, 2021
T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis.
Journal: The Journal of urology
Published: November 16, 2020
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
Journal: International journal of cancer
Published: August 06, 2020
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer.
Journal: Molecular oncology
Published: July 24, 2020
Last Updated: 09/26/2026